When you contact our customer service, we process the following data: 3.1.4
doi:10.1016/j.eclinm.2022.101691 49
Nausea is the predominant symptom, particularly during dose escalation phases, followed by vomiting, diarrhea, constipation, and abdominal discomfort
For that reason, any decision to pause or stop GLP-1 therapy should always be made in consultation with a qualified healthcare provider who can document the plan, adjust dosing, and help protect continued coverage
Unlike osmotic laxatives, which draw water out of the stool, these agents push water into the stool and soften it, which helps it to move through the colon